Skip to main content

Stanley Cohen Archives

Hodges, Nakagawa receive Cohen Innovation funds

Sep. 14, 2022—Emily Hodges, PhD, assistant professor of Biochemistry, and Terunaga Nakagawa, MD, PhD, associate professor of Molecular Physiology and Biophysics, were named as the 2022 recipients of Stanley Cohen Innovation Funds

Read more


Nobel Prize-winning biochemist Stanley Cohen dies at 97

Feb. 6, 2020—Vanderbilt University biochemist Stanley Cohen, PhD, whose discovery of epidermal growth factor (EGF) and its receptor earned him a Nobel Prize and opened the door to a new class of cancer therapies, died Wednesday, Feb. 5, in Nashville. He was 97.

Read more


Exhibit translates scientific discoveries into art celebrating Vanderbilt’s Nobel laureates

Oct. 13, 2017—A new exhibit on display at the Wond'ry honors the discoveries of Vanderbilt's Nobel laureates by translating them into beautiful works of art.

Read more


Call for applications: 2017 Stanley Cohen Innovation Fund

Feb. 28, 2017—The Vanderbilt University School of Medicine is now soliciting applications for research awards from the Stanley Cohen Innovation Fund.

Read more


New fund honors spirit of Cohen’s innovative research

Aug. 25, 2016—When Tom Daniel, M.D., joined the Vanderbilt University faculty in December 1986, Stanley Cohen, Ph.D., had just been awarded the Nobel Prize in Physiology or Medicine for his discovery of epidermal growth factor (EGF).

Read more


VU study identifies new mechanism for cancer development

Jun. 6, 2013—Researchers at Vanderbilt University Medical Center led by a 32-year-old postdoctoral fellow have discovered a new mechanism for the development of cancer that is challenging conventional scientific wisdom.

Read more


Nobel in Chemistry reveals VU ties that bind

Oct. 18, 2012—Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more